Skip to main content

Table 2 Patient characteristics

From: Cost-minimization analysis of adjuvant chemotherapy regimens given to patients with colorectal cancer in Japan

  CapeOX mFOLFOX6 UFT/LV Capecitabine S-1 P
Gender†
 Male/female 32/25 5/5 20/18 10/10 18/11 0.909a
Age‡ 65.0 (79-40) 55.5 (73-41) 67.0 (79-40) 60.0 (78-40) 63.0 (80-42) 0.309b
Tumor type
 Colon cancer/rectal cancer† 35/22 9/1 27/11 15/5 17/12 0.372a
Stage†
 I / II / III 0/3/54 0/0/10 0/11/27 0/2/18 4/11/14 <0.001a
Performance status†
 0/1 57/0 10/0 35/3 18/2 29/0 0.0680a
  1. †Number; ‡Median (range)
  2. aχ2 test; bAnalysis of variance